Lensar (LNSR) Retained Earnings (2019 - 2026)
Lensar (LNSR) reported Retained Earnings of -$141.2 million for Q1 2026, up 17.23% year-over-year from -$120.5 million in Q1 2025, and down 3531175.0% on a QoQ basis from $4000.0 in Q4 2025.
Lensar (LNSR) has 8 years of Retained Earnings data on file, last reported at -$141.2 million in Q1 2026.
- Quarterly Retained Earnings rose 17.23% year-over-year to -$141.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$141.2 million (up 17.23% YoY) and the FY2025 annual result came in at $4000.0, up 100.0% from the prior year.
- Retained Earnings eased to -$141.2 million in Q1 2026 per LNSR's latest filing, from $4000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $15000.0 in Q3 2024 and bottomed at -$176.1 million in Q3 2025.
- The 5-year median for Retained Earnings is -$108.0 million (2023), against an average of -$101.6 million.
- The widest annual swing landed in 2024, when Retained Earnings surged 100.01%; it then plunged 17063900.0% in 2025.
- Tracing LNSR's Retained Earnings over 5 years: stood at -$97.5 million in 2022, then slipped by 14.75% to -$111.9 million in 2023, then dropped by 28.07% to -$143.3 million in 2024, then surged by 100.0% to $4000.0 in 2025, then plunged by 3531175.0% to -$141.2 million in 2026.
- Per Business Quant, the three latest LNSR Retained Earnings figures stand at -$141.2 million (Q1 2026), $4000.0 (Q4 2025), and -$176.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 49.96 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 32.30 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -398.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -221.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 106.20 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 5.65 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -113.10 Mn |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn | -141.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -141.24 Mn |
| Dec 31, 2025 | 4,000.00 |
| Sep 30, 2025 | -176.12 Mn |
| Jun 30, 2025 | -172.40 Mn |
| Mar 31, 2025 | -170.64 Mn |
| Dec 31, 2024 | -143.30 Mn |
| Sep 30, 2024 | 15,000.00 |
| Jun 30, 2024 | -123.09 Mn |
| Mar 31, 2024 | -1,000.00 |
| Dec 31, 2023 | -111.89 Mn |
| Sep 30, 2023 | -107.97 Mn |
| Jun 30, 2023 | -110.53 Mn |
| Mar 31, 2023 | -101.78 Mn |
| Dec 31, 2022 | -97.51 Mn |
| Sep 30, 2022 | -95.02 Mn |
| Jun 30, 2022 | -91.03 Mn |
| Mar 31, 2022 | -84.27 Mn |
| Dec 31, 2021 | -77.59 Mn |
| Sep 30, 2021 | -73.69 Mn |
| Jun 30, 2021 | -67.54 Mn |
| Mar 31, 2021 | -63.18 Mn |
| Dec 31, 2020 | -57.99 Mn |
| Sep 30, 2020 | -51.17 Mn |
| Dec 31, 2019 | -38.19 Mn |